Skip to main content

Table 1 Phases of the engaging community pharmacy in tuberculosis case detection (ENHANCE) study, conducted in Bandung, Indonesia from February- November 2025

From: Engaging community pharmacy in tuberculosis case detection (ENHANCE): a study protocol for an implementation study in Indonesia

Study Phase

Phase’s title

Objectives

Activities

Outputs

Timeline

I

Building coalition

To engage all stakeholders and key actors for successful program implementation

1. FGDs

2. IDIs

3. Informal discussion

A joint agreement and statement of key actors to participate in the program implementation

February-March 2025

II

Program development

1. To adapt the theoretical conceptual model of the program into the local context

2. To mitigate potential barriers in the program implementation; and

3. To develop intervention packages for the successful implementation of the program.

1. Literature Review

2. IDIs

3. FGDs

1. An adapted conceptual model for program implementation

2. Program guidance, training material and practice aids for the program implementation

April-May 2025

III

Socialization and capacity building

1. To socialize the program concept and its instrument aids to the key actors and implementers.

2. To improve the capacity of the implementers for program implementation.

3. To receive a strong commitment from the implementers for the study’s implementation.

A two-day certified workshop

1. Improving the capacity of implementers on knowledge and skills related to TB case detection

2. A joint agreement and statement of the implementer to participate in the program implementation

June-August 2025

IV

Implementation and Evaluation

1. To implement the developed program

2. To evaluate the developed program

1. A three-month program implementation

2. Program monitoring and supervision

3. FGD

1. Effectiveness of the program, i.e., (1) the number of pharmacy visitors who receive TB screening by pharmacy personnel; (2) the number of pharmacy visitors with presumed TB referred to the CHC; (3) the number of pharmacy visitors who receive TB examination; and (4) the number of pharmacy visitors who are TB positive

2. Implementation program, i.e., key factors of success in the program implementation

September-November 2025

  1. Note: FGDs: Focus Group Discussions; IDIs: In-depth Interviews